Skip to main content
Equibles
CABR logo

CABR · Caring Brands, Inc.

Track CABR — free

Use CABR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CABR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.40 +0.05 (+3.70%)
Rebalance outlook locked
Market Cap
$12.23M
Shares
10.37M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.35 Open$1.26 Day$1.22–1.35 Available close range$0.75–1.61 Avg vol 30d75K Short int23K · 0.2% float · 1.0d Short vol39% DataNov 2025–Sep 2026 Filing10-Q · Aug 13

The closing range uses available history since Nov 17, 2025; less than a full year is stored.

Up next

Latest filing: 10-Q
filed Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$4,215
Trailing 12 months
Net income (TTM)
−$7.73M
Trailing 12 months
Revenue growth YoY
-9.9%
Year over year
Operating margin
-140,807.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-32.6%
Year over year · fewer shares
Price change (1Y)
—
Trailing year
Short interest
0.2%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +20%
above
Price vs 50-day avg −1%
below
RSI (14) 54
neutral
MACD trend Positive
52-week position 70%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Strong
1-month return −3%
trailing
6-month return +27%
trailing
YTD return +57%
this year
Relative strength +9%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Accumulating
+67% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.23% of float · ▲ +281.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
10 holders — 13F breadth
Squeeze score 50
elevated · 0–100
Fundamentals
Excellent
Gross margin 56%
Balance sheet $2.1M
net cash
Quant / Vol
risk profile
Very High
Volatility 124%
annualized · 1-yr
Max drawdown −51%
past year
ATR 9.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+20% Bullish
Price vs 50-day avg
−1% Neutral
RSI (14)
54 Neutral
MACD trend
Positive Bullish
52-week position
70% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Accumulating
+67% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.23% of float · ▲ +281.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
10 holders — 13F breadth
Price context
position in its available closing range
Range low $1 Now $1 · 70% Range high $2
vs 200-day avg +20% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CABR
Caring Brands, Inc.
this stock
$12.23M +57.3% — — 0.2%
TAK
Takeda Pharmaceutical Co Ltd
 $59.80B +22.2% — — 0.1%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
 $51.90B — — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $45.49B +25.6% +4.3% 64.0 3.2%
GALDY
Galderma Group AG/ADR
 $44.48B -8.0% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
10
% held
1.5%
Net QoQ
-47.5K sh
Top holder
FRANKLIN RESOURCES INC
Held Float
View
Held by Funds
Fund positions
3
View
Short & Settlement
Short Interest Rising
Shares short
23.4K
Days to cover
1.0d
Change
+17.3K sh
View
Short Volume
Short vol %
39%
As of
Sep 18, 2026
Short Total
View
Fails to Deliver
FTD shares
66
Value
$92
As of
Aug 31, 2026
View
Off-Exchange
Off-exchange %
71.3%
Week of
Aug 10, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$4.2K
Net income (FY)
$-6.3M
EPS diluted
$-0.46
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 11, 2026
This year
21
View
Exempt Offerings
Offering
$3.0M
Filed
Apr 23, 2024
View

Performance

5D 20D 120D MTD YTD
CABR +18.4% -2.9% +27.4% +0.8% +57.3%
SPY +0.6% -0.8% +18.2% -0.6% +11.8%
vs SPY +17.8% -2.0% +9.1% +1.3% +45.5%
Key facts CIK 2020737 CUSIP 14216J109 Visit website Investor relations